aMoon Fund
Venture Capital
Active
Raanana, Israel
53
57M
37
6.62
15
0.30
3
- Areas of investment
Summary
aMoon Fund appeared to be the VC, which was created in 2016. The company was established in Asia in Israel. The main department of described VC is located in the Ra'anana.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the aMoon Fund, startups are often financed by Lightspeed Venture Partners, Elron Electronic Industries, OurCrowd. The meaningful sponsors for the fund in investment in the same round are Lightspeed Venture Partners, Pacific 8 Ventures, OurCrowd. In the next rounds fund is usually obtained by Samsung NEXT, Oxford Finance LLC, Longliv Ventures.
The current fund was established by Yair Schnidel.
Considering the real fund results, this VC is 63 percentage points more often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 2-6 investment rounds annually. The top activity for fund was in 2019.
Among the most successful fund investment fields, there are Medical Device, Big Data. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Israel. The fund has no specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight DayTwo, Medial EarlySign, CartiHeal.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
- Check size
- 10M — 30M
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- USD 340000000
- Fund raised date
- 2022-07-20
Analytics
- Total investments
- 53
- Lead investments
- 15
- Exits
- 3
- Rounds per year
- 6.62
- Follow on index
- 0.30
- Investments by industry
- Health Care (34)
- Biotechnology (31)
- Medical (21)
- Life Science (12)
- Medical Device (11) Show 24 more
- Investments by region
-
- United States (32)
- Israel (19)
- United Kingdom (1)
- Switzerland (1)
- Peak activity year
- 2021
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 380M
- Group Appearance index
- 0.89
- Strategy success index
- 0.60
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| AltruBio | 21 May 2024 | Biotechnology, Health Care, Medical | Early Stage Venture | 225M | United States, California |
| Eleos Health | 13 Sep 2021 | Health Care | Seed | 6M | United States, Massachusetts, Cambridge |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.